发表刊物

近五年内第一/通讯作者（含共同）发表论文情况：

2023年

Zhang YM#, Liu XZ#, Zhang Z, Zhou TC, Zhang X, Yang HY, Tan M, Hu N, Shi SF, Wang F, Xu R, Liu LJ, Wang SX, Liu G, Zhou FD, Zhao MH, Zhang H, Lv JC*, Zhang YP*, Zhang ZJ*, Yang L*. Clinicopathological and immunological features of new onset kidney disease: a rare event after SARS-CoV-2 vaccination. Natl Sci Rev. 2023;10(5):nwac034. (Article, Q1, IF= 23.178)

Zhang YM#, Luo MT#, Wu Q, Wang YX, Ma X, Yan G, Zhang SH, Chen Y, Wan N, Zhang L, You D, Wei J*, Zhang ZJ*, Zhou TC*; Precise-CoVaccine study group. Long-term and effective neutralization against omicron sublineages elicited by four platform COVID-19 vaccines as a booster dose. Cell Discov. 2023;9(1):17.  (Research letter, Q1, IF = 38.09)

Zhang YM, Lv JC, Wong MG, Zhang H, Perkovic V*. Glucocorticoids for IgA nephropathy-pro. Kidney Int. 2023;103(4):666-669. (Review, Q1, IF=19.00)

Zhang YM#, Hu YT#, Lv JC, Zhang H. Corticosteroids in the treatment of IgA nephropathy: lessons from the TESTING trial. Pediatr Nephrol. 2023 Mar 7. (Review, Q2, IF= 3.65)

2022年

Zhang YM#, Ma XP#, Yan GH#, Wu Y#, Chen YL, Zhou ZM, Wan N, Su W, Liu FW, Dai MX, Yang M, Li CM, Yu XJ, Zhang L, Wang ZF*, Zhou TC*, You DY*, Wei J*, Zhang ZJ* on be half of the Precise-CoVaccine study group. Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial. eClinicalMedicine.2022 54:101680. (Article, Q1, IF= 17)

Zheng J#*, Zhang YM#, Zhao HL#, Liu Y#, Baird D, Karim MA, Ghoussaini M, Schwartzentruber J, Dunham I, Elsworth B, Roberts K, Compton H, Molloy FM, Liu XZ, Wang L, Zhang H, Smith GD, Gaunt TR*. Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity. EBioMedicine. 2022; 81: 104112. (Article, Q1, IF= 11.205)

Zhang YM#, Liu XZ#, Lin MM#, Zan JC#, Hu YT#, Wang XQ#, Wu WQ, Zhou TC, Lv JC*, Zhang H*, Yang L*, Zhang ZJ*. Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients. J Infect. 2022;85(2):174-211. (Letter, Q1, IF= 38.637)

Zheng J#*, Zhang YM#*, Rasheed H#, Walker V, Sugawara Y, Li J, Leng Y, Elsworth B, Wootton RE, Fang S, Yang Q, Burgess S, Haycock PC, Borges MC, Cho Y, Carnegie R, Howell A, Robinson J, Thomas LF, Brumpton BM, Hveem K, Hallan S, Franceschini N, Morris AP, Köttgen A, Pattaro C, Wuttke M, Yamamoto M, Kashihara N, Akiyama M, Kanai M, Matsuda K, Kamatani Y, Okada Y, Walters R, Millwood IY, Chen Z, Davey Smith G, Barbour S, Yu C*, Åsvold BO*, Zhang H#*, Gaunt TR#*. Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease. Int J Epidemiol. 2022: 50(6):1995-2010. (Article, Q1, IF= 9.685)

2021年

Zhang Z#, Zhang G#, Guo M#, Tao W#, Liu X, Wei H, Jin T*, Zhang YM*, Zhu S*. The Potential Role of an Aberrant Mucosal Immune Response to SARS-CoV-2 in the Pathogenesis of IgA Nephropathy. Pathogens. 2021;10(7):881. (Article, Q2, IF= 4.531)

Zhang YM, Zhou XJ, Wang YN, Liu XZ, Wang YF, Lau YL, Yang WL, Zhang H*. Shared genetic study gives insights into the shared and distinct pathogenic immunity components of IgA nephropathy and SLE. Mol Genet Genomics. 2021;296(4):1017-1026. (Article, Q3, IF= 2.980)

Zhang YM#, Liu XZ#, Zhou XJ, Liu LJ, Shi SF, Hou P, Lv JC, Zhang H*. A Functional Variant rs3093023 in CCR6 Is Associated With IgA Nephropathy by Regulating Th17 Cells in a North Han Chinese Population. Front Immunol. 2021;12:600598. (Article, Q1, IF= 8.786)

Zhang YM*, Wang YF, Rasheed H, Ott J. Editorial: Multi-Omics Study in Revealing Underlying Pathogenesis of Complex Diseases: A Translational Perspective. Front Genet. 2021,12:789294. (Editorial, Q1, IF=4.772)

2020年

Zhang YM. First Case of Covid-19 in the United States. N Engl J Med. 2020;382(21):e53. (Letter, Q1, IF= 176.079)

Zhang YM#, Guo L#, Wang Z, Wang J, Er L, Barbour SJ, Trimarchi H*, Lv J*, Zhang H. External Validation of International Risk-Prediction Models of IgA Nephropathy in an Asian-Caucasian Cohort. Kidney Int Rep. 2020;5(10):1753-1763. (Article, Q1, IF= 6.234)

Zhang YM, Zhang H*. Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Clin J Am Soc Nephrol. 2020;15(7):1044-1046. (Review, Q1, IF= 10.614)

Zhang YM#, Zheng J#*, Gaunt TR, Zhang H*. Mendelian Randomization Analysis Reveals a Causal Effect of Urinary Sodium/Urinary Creatinine Ratio on Kidney Function in Europeans. Front Bioeng Biotechnol. 2020;8:662. (Article, Q1, IF= 6.064)

Zhang YM#, Wang L#, Liu XZ, Zhang H*. The COVID-19 Pandemic from a Human Genetic Perspective. J Proteome Res. 2020;19(11):4374-4379. (Review, Q1, IF=5.370)

Zhang YM, Zhou XJ, Shi SF, Liu LJ, Lyu JC, Zhang H*. Homocysteine and IgA nephropathy: observational and Mendelian randomization analyses. Chin Med J (Engl). 2020;133(3):277-284. (Article, Q1, IF= 6.133)

2019年

康玉琦, 张月苗*, 侯 平, 师素芳, 刘立军, 周绪杰, 吕继成, 张 宏. IgA肾病易感基因遗传多态性的种族差异分析. 北京大学学报（医学版）. 2019;51(03):459-466. (论著, 北大核心)

2018年

Zhang YM, Zhang H*. Insights into the Role of Mucosal Immunity in IgA Nephropathy. Clin J Am Soc Nephrol. 2018;13(10):1584-1586. (Review, Q1, IF= 10.614)

Zhang YM, Zhang H*. Update on treatment of immunoglobulin A nephropathy. Nephrology (Carlton). 2018;23 Suppl 4:62-67. (Review, Q3, IF= 2.358)

2017年

Zhang YM#, Zhou XJ#, Zhang H*. What Genetics Tells Us About the Pathogenesis of IgA Nephropathy: The Role of Immune Factors and Infection. Kidney Int Rep. 2017;2(3):318-331. (Review, Q1, IF= 6.234)

Zhang YM#, Zhou XJ#, Cheng FJ, Qi YY, Hou P, Zhao MH, Zhang H*. Association of the IKZF1 5′ UTR variant rs1456896 with lupus nephritis in a northern Han Chinese population. Scand J Rheumatol. 2017;46(3):210-214. (Article, Q3, IF=3.057)